Increment in inter-reader agreement on Chest CTs
Increased sensitivity on CTs; <1 FPs per scan
Reduction in time spent per CT
AUC (CXRs) in finding potential malignancies
CXRs processed via Incidental Detection pathways; 1100+ sites
CXRs flagged with potential malignancy risk; 27% of these had high-risk scores
World’s most widely used AI for comprehensive chest X-ray reporting. Pre-read assistance in <1 min with findings across lung, heart, pleura, mediastinum, bones, & diaphragm.
AI for CXRs
Patients referred for Lung Cancer based on screening 80,000+ individuals across 20 countries.
As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca along with Qure.ai will be screening 5 million patients by 2025.Read More
qXR detected malignant nodules with a sensitivity ranging from 0.95 to 1.00 and AUC from 0.99 to 1.
Be it lung cancer screening or incidental discovery, qCT is your trusted partner in the early detection and monitoring of lung nodules. With rapid detection, precise quantification, comprehensive characterization, and detailed 3D visualization at your fingertips, qCT ensures you never miss an opportunity for early detection.
AI for Lung CTs
Schedule a Demo
Explore how qLC-Suite can add value to your care cascades and get a guided walkthrough of our capabilities.